Davis's Drug Guide
gemcitabine
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
jem-site-a-been
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Avgemsi
- Gemzar
Ther. Class.
Pharm. Class.
antimetabolites
nucleoside analogues
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Gemcitabine." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/51352/all/gemcitabine.
Vallerand AHA, Sanoski CAC, . Gemcitabine. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51352/all/gemcitabine. Accessed April 6, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Gemcitabine. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51352/all/gemcitabine
Vallerand AHA, Sanoski CAC, . Gemcitabine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 06]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51352/all/gemcitabine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - gemcitabine
ID - 51352
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/51352/all/gemcitabine
PB - F.A. Davis Company
ET - 19
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -